A recent study has revealed that three out of four women in middle-income countries, including Bangladesh, face an increased risk of ovarian cancer. This finding stems from a study conducted jointly by the World Ovarian Cancer Coalition (WOCC) and the International Gynecologic Cancer Society (IGCS). Rafe Sadnan Adel, founder and chairman of Cancer BD, as well as a board member of WOCC, revealed this result during the IGCS annual meeting held in Dublin, Ireland, on Thursday. Adel was also a member of the oversight committee for the research project. Cancer survivors call for mental health support, more hospitals in Bangladesh The study ‘The Every Woman Study’ came up with the finding, analysing data from 2,446 women across 22 low and middle income countries facilitated by the World Ovarian Cancer Coalition, a Canadian NGO, said Adel. The study was conducted in 82 hospitals in 28 different languages. The study set out to define challenges and opportunities to improve survival and quality of life for women diagnosed with ovarian cancer in resource limited settings. The study team, led by Frances Reid included experts such as Sahana Parveen, Clara Makewe, Irene Lo, Florencia Nol, Sara Nasser, Basel Refki, Asima Mukhopadhyay, Tracy Adams, Raikhan Bolatbekova, Dilwara Kaidarova, Garth Funston, Nzok Phan, Eva Maria Stromslom, Ransi Chibaba, Robyn Cohen, Martin Origa, Isabella Ciorgiumataram, Fedra Carlton, and Mary Eiken. Newspapers’ role crucial in raising awareness of antimicrobial resistance: icddr,b According to Adel, the study found that the mortality rate for ovarian cancer could increase from 55% to 70% in the coming years. He emphasized the urgent need for targeted awareness campaigns to help prevent this type of cancer. Some key findings of the study include the following: In low- and middle-income countries: * Two-thirds of women know nothing about ovarian cancer. * Nine out of ten women only learn about ovarian cancer symptoms at the time of diagnosis. * One-fourth of the women start seeking treatment after six months after symptom onset. * None explore their family history for potential risk factors. * Only 16% of women receive psychological support during this time. Adel lost his mother to cancer in 2014. The same year he launched Cancer BD, the first Bangla-language website dedicated to providing information about cancer (www.cancerbd.net). Since 2021, he has also served on the board of the World Ovarian Cancer Coalition, an international alliance of over 200 organizations working on ovarian cancer awareness and prevention worldwide.  

Johnson & Johnson is asking for Supreme Court review of a $2 billion verdict in favor of women who claim they developed ovarian cancer from using the company’s talc products. The case features an array of high-profile attorneys, some in unusual alliances, including former independent counsel Kenneth Starr, who is representing the women who sued Johnson & Johnson. The nation’s largest business groups are backing the company, and a justice’s father also makes an appearance because of his long association with the trade group for cosmetics and personal care products. Read:Apple brings CEO Tim Cook to court in defense of app store The court could say as soon as Tuesday whether it will get involved. At the root, Johnson & Johnson argues that the company didn’t get a fair shake in a trial in state court in Missouri that resulted in an initial $4.7 billion verdict in favor of 22 women who used talc products and developed ovarian cancer. A state appeals court cut more than half the money out of the verdict and eliminated two of the plaintiffs, but otherwise upheld the outcome in a trial in which lawyers for both sides presented dueling expert testimony about whether the company’s talc products contain asbestos and asbestos-laced talc can cause ovarian cancer. The jury found for the women on both points, after which Judge Rex M. Burlison wrote that evidence at the trial showed “particularly reprehensible conduct on the part of Defendants.” The evidence, Burlison wrote, included that the company knew there was asbestos in products aimed at mothers and babies, knew of the potential harm and “misrepresented the safety of these products for decades.” Nine of the women have died from ovarian cancer, lawyers for the plaintiffs said Johnson & Johnson denies that its talc products cause cancer and it called the verdict in the Missouri trial “at odds with decades of independent scientific evaluations confirming Johnson’s Baby Powder is safe, is not contaminated by asbestos and does not cause cancer.” The company also is the maker of one of three COVID-19 vaccines approved for use in the United States. Health concerns about talcum powders have prompted thousands of U.S. lawsuits by women who claim asbestos in the powder caused their cancer. Talc is a mineral similar in structure to asbestos, which is known to cause cancer, and they are sometimes obtained from the same mines. The cosmetics industry in 1976 agreed to make sure its talc products do not contain detectable amounts of asbestos. Last year, a U.S. government-led analysis of 250,000 women found no strong evidence linking baby powder with ovarian cancer in the largest analysis to look at the question, though the study’s lead author called the results “very ambiguous.” Read:Asian shares mixed after retreat on Wall Street The findings were called “overall reassuring” in an editorial published with the study in January 2020 in the Journal of the American Medical Association. The study wasn’t definitive but more conclusive research probably isn’t feasible because a dwindling number of women use powder for personal hygiene, the editorial said. A few months later, the company announced it would stop selling its iconic talc-based Johnson’s Baby Powder in the U.S. and Canada, citing declining demand driven by what it called misinformation about health concerns. The disputed link between cancer and talc is not really a part of the high court case. Instead, the company said it should have not been forced to defend itself in one trial against claims by women from 12 states, differing backgrounds and with varying histories of using Johnson & Johnson products containing talc. The $1.6 billion in punitive damages is out of line and should be reduced, the company also argued in a brief that was written by Neal Katyal, a Washington lawyer who aligns with progressive causes and also represents corporate clients. Katyal, who was the acting top Supreme Court lawyer for a time in the Obama administration, declined an on-the-record interview. The U.S. Chamber of Commerce and trade associations for manufacturers, insurers and the pharmaceutical industry are among the business organizations backing Johnson & Johnson’s appeal. Tiger Joyce, president of the American Tort Reform Association, pointed to how long it took the trial judge to read the jury its instructions as an indication of how unfair the trial was to Johnson & Johnson. “When a defendant is facing a case where it takes over five hours for the judge to read the jury instructions to the jury, you just have to ask yourself what are we doing here,” said Joyce, whose group generally backs limits on liability lawsuits. Starr said in an interview with The Associated Press that none of Johnson & Johnson’s legal arguments is worth the court’s time. “As the jury found and as every judge to review this six-week trial record has concluded, Johnson & Johnson’s conduct over decades was reprehensible,” Starr said. In addition to Starr, other members of the women’s legal team are former Attorney General John Ashcroft and Washington lawyers David Frederick and Tom Goldstein, frequent advocates before the Supreme Court. Justice Brett Kavanaugh worked for Starr when he investigated the affair between President Bill Clinton and Monica Lewinsky, which led to Clinton’s impeachment. Read:Oprah and CNN: AT&T is merging media business with Discovery Another name that pops up in some documents in the case is E. Edward Kavanaugh, who was the longtime president of the Cosmetic, Toiletry and Fragrance Association and is the justice’s father. Kavanaugh’s group fought efforts to list talc as a carcinogen or attach warning labels to talc products. Kavanaugh is retired and the group now is called the Personal Care Products Council. Ethicists contacted by the AP said they haven’t seen anything that would warrant the justice having to step aside from the case. Already, one justice almost certainly won’t take part. Justice Samuel Alito reported last year that he owned $15,000 to $50,000 in Johnson & Johnson stock. Federal law prohibits judges from sitting on cases in which they have financial interest.